In this episode, Will Tjernlund interviews John Yu, CEO of Kairos Pharma, who shares his journey from medical school to leading a biotech company focused on reversing cancer drug resistance. John discusses the innovative therapies being developed at Kairos Pharma, the importance of personalized medicine, and the challenges of navigating FDA approval processes. He also reflects on the future of the company and the broader impact of their work in the field of immunology and cancer treatment.
Kairos Pharma Website
المعلومات
- البرنامج
- معدل البثيتم التحديث أسبوعيًا
- تاريخ النشر١٠ جمادى الأولى ١٤٤٦ هـ في ١١:٢٦ ص UTC
- مدة الحلقة٣٠ من الدقائق
- الحلقة٢٠
- التقييمملائم